dupilumab
sanofi,regeneron
['dupilumab', 'derm']
from #aad2023 this morning: #dupilumab is the first biologic to be evaluated for hand and foot atopic dermatitis. over half of the patients saw clear/almost clear results. check out the latest data here: #eczema #dermatology
Clinical News for Connected Physicians. Everything you need to enhance your clinical approach to improving patient care.